116 related articles for article (PubMed ID: 8655006)
21. Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
Lazzarin A; Luerti M; Uberti-Foppa C; Zavattini G; Rossi A; Tornaghi R
Biol Res Pregnancy Perinatol; 1984; 5(3):130-4. PubMed ID: 6478010
[TBL] [Abstract][Full Text] [Related]
22. [Ambroxol in the treatment of idiopathic respiratory distress syndrome].
Durisová A
Cesk Pediatr; 1992 Jul; 47(7):421-3. PubMed ID: 1394543
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials.
Wu X; Li S; Zhang J; Zhang Y; Han L; Deng Q; Wan X
J Clin Pharmacol; 2014 Nov; 54(11):1199-206. PubMed ID: 25174313
[TBL] [Abstract][Full Text] [Related]
24. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
25. [Prenatal prevention of infant respiratory distress syndrome. 2nd part: clinical applications and indications].
Lenclen R; Paupe A; Philippe HJ; Olivier-Martin M; Nisand I
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):294-309. PubMed ID: 7622778
[TBL] [Abstract][Full Text] [Related]
26. A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS).
Lazzarin A; Luerti M; Capsoni F; Galli M; Uberti-Foppa C; Zavattini G; Corbella E
Int J Tissue React; 1986; 8(2):157-65. PubMed ID: 3700005
[TBL] [Abstract][Full Text] [Related]
27. Effects of antenatal and postnatal corticosteroids on the preterm lung.
Vyas J; Kotecha S
Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F147-50. PubMed ID: 9377142
[No Abstract] [Full Text] [Related]
28. [Ambroxol versus betamethasone for the promotion of antepartum lung maturity in pathological pregnancies].
Heytmanek G; Salzer H; Vityska-Binstorfer E; Genger H; Metka M; Pfersmann R; Wolff F; Weidinger H
Wien Klin Wochenschr; 1990 Aug; 102(15):443-8. PubMed ID: 2402930
[TBL] [Abstract][Full Text] [Related]
29. [Application of exogenous surfactant and recruitment maneuver in newborns with respiratory distress-syndrome].
Aleksandrovich YS; Pechueva OA; Pshenisnov KV
Anesteziol Reanimatol; 2014; (2):47-52. PubMed ID: 25055494
[TBL] [Abstract][Full Text] [Related]
30. Effects of surfactant treatment on gas-exchange and clinical course in near-term newborns with RDS.
Golombek SG; Truog WE
J Perinat Med; 2000; 28(6):436-42. PubMed ID: 11155428
[TBL] [Abstract][Full Text] [Related]
31. Vitamin A is systemically bioavailable after intratracheal administration with surfactant in an animal model of newborn respiratory distress.
Singh AJ; Bronshtein V; Khashu M; Lee K; Potts JE; Friel J; Chessex P
Pediatr Res; 2010 Jun; 67(6):619-23. PubMed ID: 20216104
[TBL] [Abstract][Full Text] [Related]
32. Mucolytics and antioxidant activity.
Strapková A; Nosál'ová G; Franová S
Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
[TBL] [Abstract][Full Text] [Related]
34. [Effect of lipine, a new antihypoxic agent on some respiratory indices in newborn infants after asphyxia].
Cherniĭ OF; Seredenko MM; Sidelńykov VM
Fiziol Zh (1978); 1992; 38(6):25-30. PubMed ID: 1340448
[TBL] [Abstract][Full Text] [Related]
35. [Use of ambroxol in the therapy of neonatal respiratory insufficiency].
Colombo ML; Dogliani P; Ulla L
Minerva Pediatr; 1988 Jun; 40(6):333-8. PubMed ID: 3185433
[No Abstract] [Full Text] [Related]
36. [Clinical research on high-dosage ambroxol hydrochloride associated with ulinastatin in improvement of lung tissue injury of patients with paraquat poisoning].
Wang WS; Guan JY; Lu QL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Jan; 28(1):58-60. PubMed ID: 20426988
[No Abstract] [Full Text] [Related]
37. Acute and sustained effects of lucinactant versus poractant-alpha on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome.
Gastiasoro-Cuesta E; Alvarez-Diaz FJ; Rey-Santano C; Arnaiz-Renedo A; Loureiro-Gonzalez B; Valls-i-Soler A
Pediatrics; 2006 Feb; 117(2):295-303. PubMed ID: 16452346
[TBL] [Abstract][Full Text] [Related]
38. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
[TBL] [Abstract][Full Text] [Related]
39. The therapeutic efficacy of high-dose ambroxol and the nursing effects in the treatment of severe pneumonia.
Wang D; Sun S; Hu S
Pak J Pharm Sci; 2019 May; 32(3 Special):1409-1413. PubMed ID: 31551222
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of treating neonates with surfactants for respiratory distress syndrome. I. Importance of gas exchange].
Gadzinowski J; Szymankiewicz M; Twarowska I; Halliday H
Ginekol Pol; 1992; 63(3):101-4. PubMed ID: 1303908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
